Guardant Health, Inc. - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
GH Nasdaq 8081 guardanthealth.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Guardant Health, Inc.

Dow Jones Futures: S&P 500 Hits High As Astera, GE Vernova, Arista Lead Buys, But These Stocks Tumble - Oct 6th, 2026 10:39 pm
Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Melanoma - Oct 5th, 2026 9:27 am
3 Cash-Burning Stocks with Questionable Fundamentals - Oct 5th, 2026 3:39 am
These IBD 50 Stocks Are Stalled. That Could Be A Good Thing. - Oct 2nd, 2026 6:00 am
Abbott launches Freenome’s colorectal cancer screening test - Sep 30th, 2026 8:58 am
1 Mid-Cap Stock for Long-Term Investors and 2 We Ignore - Sep 29th, 2026 8:08 am
Coverbase Adds Third-Party Risk Veterans as Enterprise Adoption Accelerates - Sep 29th, 2026 7:15 am
FDA Advisors Said It Should Approve the Grail Multicancer Blood Test. The Stock Rises Sharply. - Sep 24th, 2026 8:52 am
Dow Jones Futures Fall After Nasdaq Hits New High; Sandisk, Micron Trigger Buy Signals - Sep 23rd, 2026 6:05 am
AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why. - Sep 21st, 2026 2:00 pm
Cathie Wood Makes a Big AI Bet and Cuts Bitcoin Exposure - Sep 21st, 2026 1:23 pm
1 Unpopular Stock That Should Get More Attention and 2 We Question - Sep 21st, 2026 1:26 am
Guardant Health (GH) Lands First FDA Cleared Breast Cancer Liquid Biopsy Role - Sep 17th, 2026 11:14 pm
Testing & Diagnostics Services Stocks Q2 Results: Benchmarking Guardant Health (NASDAQ:GH) - Sep 16th, 2026 11:00 am
Guardant Health Nears Buy Point As Sales Outlook Brightens - Sep 16th, 2026 10:39 am
Dow Jones Futures Rise As Oil Prices, Yields Fall Before Fed Rate Hike; Will Market Rally Bid Bond Voyage? - Sep 16th, 2026 6:07 am
Cathie Wood's ARK Invest Buys AVAV Stock Again, Trims GOOGL Stake And Sells Iridium - Sep 16th, 2026 4:31 am
Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says - Sep 15th, 2026 1:02 pm
Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening - Sep 14th, 2026 2:05 pm
Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer - Sep 9th, 2026 1:46 pm